Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study
Diabetic Medicine · 2026-03 · 43 (3)
DOI: 10.1111/dme.70194 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetic Medicine, online erschienen am 23.01.2026. Verfasst von Aisling McCarthy und 10 weiteren Autor:innen. Beteiligte Einrichtung: University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Hypoglycemia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Insulin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking (JU).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
The mental health impact of impaired awareness of hypoglycaemia (IAH) in people with type 2 diabetes (T2D) is not known. We explored this in people with insulin‐treated T2D and type 1 diabetes (T1D).
Methods
Hypo‐METRICS was a 10‐week cross‐sectional observation of hypoglycaemia experience, collecting data on glucose and activity.
Participants
(325 insulin‐treated T2D, 277 T1D) completed questionnaires scoring depression (PHQ‐9), anxiety (GAD‐7), diabetes distress (PAID) and fear of hypoglycaemia (HFS‐II [worry]) at baseline. IAH was defined as a Gold score ≥4. Relationships between IAH and mental health scores were explored using unadjusted and adjusted generalised linear regression analyses. Age, sex, race, diabetes duration, level of education, employment status, continuous glucose monitoring (CGM) use, hypoglycaemia, use of anti‐depressants and use of anti‐anxiety medications were covariates in the adjusted regression.
Results
In unadjusted regression in insulin‐treated T2D, IAH was associated with higher PHQ‐9 (6.4% [1.5%–11.3%]; p = 0.011), GAD‐7 (7.6% [2.1%–13%]; p = 0.006) and HFS‐II (worry) (7.4% [2.8%–12%]; p = 0.002) scores, with no differences in PAID ( p = 0.655). After adjustment, IAH was associated with higher HFS‐II (worry) (5.3% [0.3%–10.6%]; p = 0.048) only. In T1D, IAH was associated with higher PHQ‐9 (6.2% [1.3%–10.8%]; p = 0.012), GAD‐7 (6.1% [0.1%–12.2%]; p = 0.046) and HFS‐II (worry) (6.1% [0.06%–11.5%]; p = 0.029) scores, but not PAID ( p = 0.654), all unadjusted. These relationships remained after adjustment, which also showed higher PAID (8.43% [2.62%–14.24%]; p = 0.005).
Conclusion
Our data demonstrated associations between IAH and a greater mental health burden in both insulin‐treated T2D and T1D. Addressing these mental health challenges should be an important part of the holistic care of people with IAH and insulin‐treated diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University College Dublin, Dublin, Ireland.
- Diabetes Research Centre, University of Leicester, Leicester, UK.
- Department of Computer Sciences, Maynooth University, Maynooth, Ireland.
- Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- Department of Medical Psychology, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Psychology, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Aisling McCarthy, Jonah Thomas, Eduardo Avila, Natalie Zaremba, Stephanie A Amiel, François Pouwer, Pratik Choudhary
Förderung
- Innovative Medicines Initiative 2 Joint Undertaking (JU)
Zitieren
APA
McCarthy, A., Thomas, J., Avila, E., Koutroukas, V., Pieri, B., Zaremba, N., Amiel, S. A., Pouwer, F., Choudhary, P., Divilly, P., & Hypo‐RESOLVE Consortium (2026). Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study. Diabetic Medicine, 43(3). https://doi.org/10.1111/dme.70194
Vancouver
McCarthy A, Thomas J, Avila E, Koutroukas V, Pieri B, Zaremba N, et al. Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study. Diabetic Medicine. 2026;43(3). doi:10.1111/dme.70194
BibTeX
@article{McCarthy2026,
author = {McCarthy, Aisling and Thomas, Jonah and Avila, Eduardo and Koutroukas, Vaios and Pieri, Beatrice and Zaremba, Natalie and Amiel, Stephanie A and Pouwer, François and Choudhary, Pratik and Divilly, Patrick and Hypo‐RESOLVE Consortium, Hypo‐RESOLVE Consortium},
title = {Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study},
journal = {Diabetic Medicine},
year = {2026},
volume = {43},
number = {3},
doi = {10.1111/dme.70194}
}
EUVIMED